Herpes Simplex Virus Diagnostics Market: By Type of Test, and Anti-biotic Test), By Disease Type, By End-users, and Region Forecast 2020-2031

download arrow download arrow Download Sample
settings arrow settings arrow email us

Herpes Simplex Virus (HSV) Diagnostics Market Size, Share, Growth, Trends, and Global Industry Analysis: By Type of Test (Viral Culture Test, Nucleic Acid Amplification Test (NAATs), and Anti-biotic Test), By Disease Type (HSV-I and HSV-II), By End-users (Hospital & Clinics, Research Institutions, and Diagnostic Laboratories), and Region Forecast 2020-2031

checked icon checked icon arrow_drop_down
checked icon Single User License $4400 $3520
checked icon Multiple User License $6600 $5280
checked icon Corporate User License $8900 $7120

Herpes Simplex Virus Diagnostics Market size was valued at US$ 2.7 billion in 2024 and is expected to reach US$ 4.6 billion by 2031, growing at a significant CAGR of 8.1% from 2025-2031. Covid-19 is the main reason for expansion, where researchers have identified the link between the herpes simplex virus and the SARS-CoV-2 virus in various studies, and a rising number of HSV infections, according to the WHO estimates that 3.7 billion people under 50 have HSV-1, and 491.5 million people aged 15-49 live with HSV-2, indicating a significant and growing population requiring diagnosis,  as people become increasingly informed about the potential consequences of HSV infection, they are more likely to seek testing, driving the herpes simplex virus diagnostics market demand for diagnostics, the development of newer, more accurate HSV tests with improved sensitivity and specificity is facilitating more precise and reliable diagnoses.

Key Developments

  • In October 2023, Gilead and Assembly Biosciences established a partnership for 12 years to develop next-generation therapeutics for serious viral diseases, with an initial focus on Assembly bio’s established areas of herpes viruses, hepatitis B virus (HBV) and hepatitis D virus (HDV).
  • In October 2021, United BioPharma and the Shanghai Public Health Clinical Centre collaborated with Cheng Kung University in the Department of Microbiology to study the efficacy of UB-621, a best-in-class long-acting medication for genital herpes caused by simplex viruses 1 and 2. (HSV 1 and HSV2).

summary download arrow Download Sample

Herpes Simplex Virus Diagnostics Market Summary

Study Period

2025-2031

Base Year

2024

CAGR

8.1%

Largest Market

North-America

Fastest Growing Market

Asia-Pacific

Herpes Simplex Virus (HSV) Diagnostics Market Dynamics

High prevalence of the virus, increasing public awareness, and advancements in rapid testing technology such as nucleic acid amplification tests (NAAT), detect the presence of the viral DNA and are highly sensitive and specific, and most commonly used tests for HSV diagnosis. However, social stigma and inconsistent reimbursement policies pose challenges. The market holds promise in emerging regions such as Asia-Pacific, and Latin America with growing healthcare infrastructure and rising disposable income, and the development of multiplex tests for multiple STIs could further increase accessibility and market growth.

Herpes Simplex Virus Diagnostics Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2025-2031

Market Size in 2024

US$ 2.7 billion

Market Size in 2031

US$ 4.6 billion

Market CAGR

8.1%

By Test Type

  • Viral Culture Test
  • Nucleic acid amplification test (NAAT)
  • And Anti-Biotic Test

By Disease Type

  • HSV-I
  • HSV-II

By End User

  • Hospital & Clinics
  • Research Institutions
  • Diagnostic Laboratories

By Region

  • North America (USA, Canada)
  • Europe (Germany, UK, France, Spain, Italy , Rest of Europe)
  • The Asia Pacific (China, India, Japan, Australia, South Korea, Rest of Asia- Pacific)
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America)
  • MEA (Saudi Arabia, UAE, South Africa, Rest of MEA)

Key Features of the Report

  • The herpes simplex virus diagnostics market report provides granular level information about the market size, regional market share, historic market (2020-2024), and forecast (2025-2031)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and key strategies.
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market.
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market.
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenarios.
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter's Five Force Analysis.

Download Free Sample Report

I accept the Terms and Conditions,Disclaimers, GDPR Policy

Frequently Asked Questions

Herpes simplex virus diagnostics market size was valued at US$ 2.7 billion in 2024 and is expected to reach US$ 4.6 billion by 2031, growing at a significant CAGR of 8.1%.

Abbott Laboratories (US), Roche Diagnostics (Switzerland), Thermo Fisher Scientific (US), BD (Becton, Dickinson and Company) (US), Hologic, Inc. (US), Qiagen (Netherlands), Seegene Inc. (South Korea), Agenus Inc. (U.S.), Maruho Co., Ltd. (Japan), Sanofi (France) Norgen Biotek Corp. (Canada), Bio-Rad Laboratories, Inc. (U.S.), Meridian Bioscience, Inc. (U.S.), Teco Diagnostics (U.S.), and GSK plc. (U.K.)

Asia-Pacific is the fastest growing and North America is the dominant market in HSV diagnostics.

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1.Executive Summary
2.Global Herpes Simplex Virus Diagnostics Market Introduction 
2.1.Global Herpes Simplex Virus Diagnostics Market  - Taxonomy
2.2.Global Herpes Simplex Virus Diagnostics Market  - Definitions
2.2.1.Test Type 
2.2.2.Disease Type
2.2.3.End User
2.2.4.Region
3.Global Herpes Simplex Virus Diagnostics Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Herpes Simplex Virus Diagnostics Market Analysis, 2020 - 2024 and Forecast 2025 - 2031
4.1.  Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Herpes Simplex Virus Diagnostics Market  By Test Type , 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
5.1. Viral Culture Test
5.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Nucleic acid amplification test (NAAT)
5.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. And Anti-Biotic Test
5.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
6.Global Herpes Simplex Virus Diagnostics Market  By Disease Type, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
6.1. HSV-I
6.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. HSV-II
6.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
7.Global Herpes Simplex Virus Diagnostics Market  By End User, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
7.1. Hospital & Clinics
7.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Research Institutions
7.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Diagnostic Laboratories
7.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
8.Global Herpes Simplex Virus Diagnostics Market  By Region, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Europe
8.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Asia Pacific (APAC)
8.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Middle East and Africa (MEA)
8.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Latin America
8.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9.North America Herpes Simplex Virus Diagnostics Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
9.1. Test Type  Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Viral Culture Test
9.1.2.Nucleic acid amplification test (NAAT)
9.1.3.And Anti-Biotic Test
9.2.  Disease Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.HSV-I
9.2.2.HSV-II
9.3.  End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Hospital & Clinics
9.3.2.Research Institutions
9.3.3.Diagnostic Laboratories
9.4.  Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.4.1.United States of America (USA)
9.4.2.Canada
10.Europe Herpes Simplex Virus Diagnostics Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
10.1. Test Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Viral Culture Test
10.1.2.Nucleic acid amplification test (NAAT)
10.1.3.And Anti-Biotic Test
10.2.  Disease Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.HSV-I
10.2.2.HSV-II
10.3.  End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Hospital & Clinics
10.3.2.Research Institutions
10.3.3.Diagnostic Laboratories
10.4.  Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Germany
10.4.2.France
10.4.3.Italy
10.4.4.United Kingdom (UK)
10.4.5.Spain
11.Asia Pacific (APAC) Herpes Simplex Virus Diagnostics Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
11.1. Test Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Viral Culture Test
11.1.2.Nucleic acid amplification test (NAAT)
11.1.3.And Anti-Biotic Test
11.2.  Disease Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.HSV-I
11.2.2.HSV-II
11.3.  End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Hospital & Clinics
11.3.2.Research Institutions
11.3.3.Diagnostic Laboratories
11.4.  Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.China
11.4.2.India
11.4.3.Australia and New Zealand (ANZ)
11.4.4.Japan
11.4.5.Rest of APAC
12.Middle East and Africa (MEA) Herpes Simplex Virus Diagnostics Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
12.1. Test Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Viral Culture Test
12.1.2.Nucleic acid amplification test (NAAT)
12.1.3.And Anti-Biotic Test
12.2.  Disease Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.HSV-I
12.2.2.HSV-II
12.3.  End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Hospital & Clinics
12.3.2.Research Institutions
12.3.3.Diagnostic Laboratories
12.4.  Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.GCC Countries
12.4.2.South Africa
12.4.3.Rest of MEA
13.Latin America Herpes Simplex Virus Diagnostics Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
13.1. Test Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Viral Culture Test
13.1.2.Nucleic acid amplification test (NAAT)
13.1.3.And Anti-Biotic Test
13.2.  Disease Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.HSV-I
13.2.2.HSV-II
13.3.  End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Hospital & Clinics
13.3.2.Research Institutions
13.3.3.Diagnostic Laboratories
13.4.  Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Brazil
13.4.2.Mexico
13.4.3.Rest of LA
14. Competition Landscape
14.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
14.2.1.Merck KGaA (Germany)
14.2.2.QIAGEN (Germany)
14.2.3.Norgen Biotek Corp. (Canada)
14.2.4.Hologic Inc. (U.S.)
14.2.5.Bio-Rad Laboratories, Inc. (U.S.)
14.2.6.Meridian Bioscience, Inc. (U.S.)
14.2.7.Teco Diagnostics (U.S.)
14.2.8.GSK plc. (U.K.)
14.2.9.Agenus Inc. (U.S.)
14.2.10.Maruho Co., Ltd. (Japan)
14.2.11.Sanofi (France)
14.2.12.Abbott (U.S.)
15. Research Methodology 
16. Appendix and Abbreviations 

Key Market Players

  • Merck KGaA (Germany)
  • QIAGEN (Germany)
  • Norgen Biotek Corp. (Canada)
  • Hologic Inc. (U.S.)
  • Bio-Rad Laboratories, Inc. (U.S.)
  • Meridian Bioscience, Inc. (U.S.)
  • Teco Diagnostics (U.S.)
  • GSK plc. (U.K.)
  • Agenus Inc. (U.S.)
  • Maruho Co., Ltd. (Japan)
  • Sanofi (France)
  • Abbott (U.S.)
  • Abcam plc. (U.K.)
  • bioMérieux (France)
  • Thermo Fisher Scientific, Inc. (U.S.)
  • Hoffmann-La Roche Ltd (Switzerland)
  • DiaSorin S.p.A. (Italy)
  • Quidel Corporation (U.S.)
  • Luminex Corporation (U.S.)

Related Industry Reports

Antibiotics Market

Nucleic Acid Amplification Testing Market

Viral Inactivation Market

Herpes Marker Testing Market